1.5 billion people worldwide suffer from chronic pain and over half of them are not satisfied with their care. Remedee Labs aims to give these patients a new life.
After 10 years of pre-clinical and clinical research, Remedee Labs has developed the first integrated and personalized solution based on millimeter wave therapy to tackle chronic pain. Developed around its endorphin stimulator associated with the first patient-centered digital service platform (personal coaching, peer support…), the Remedee solution helps patients to take back control of their life on a sustainable way.
Remedee Labs was founded in 2016 in Grenoble, France, by three experts in the areas micro and nano medical technologies and biomedical research. The company now has a multidisciplinary, international team of over 35 people.
Members directory
1.5 billion people worldwide suffer from chronic pain and over half of them are not satisfied with their care. Remedee Labs aims to give these patients a new life.
After 10 years of pre-clinical and clinical research, Remedee Labs has developed the first integrated and personalized solution based on millimeter wave therapy to tackle chronic pain. Developed around its endorphin stimulator associated with the first patient-centered digital service platform (personal coaching, peer support…), the Remedee solution helps patients to take back control of their life on a sustainable way.
Remedee Labs was founded in 2016 in Grenoble, France, by three experts in the areas micro and nano medical technologies and biomedical research. The company now has a multidisciplinary, international team of over 35 people.
REMEDEE LABS
35 chemin du vieux chêne
38240 MEYLAN - FRANCE
Date of creation : 2016
Number of employees : 35
https://remedeelabs.com/
Co-founder & Executif Chairman
Jacques HUSSER
Contact
contact@remedee.com
FDA Grants Breakthrough Device Designation to Remedee Labs for its groundbreaking endorphin stimulation solution for the management of Fibromyalgia